Republicans, Democrats Gang Up on Allergan at U.S. House Hearing

Drug Industry Daily
Allergan drew bipartisan fire from U.S. House members considering issues raised by the company’s innovative scheme to shield its patents on the blockbuster dry-eye drug Restasis from challenges before the Patent Trial and Appeal Board.

To View This Article:


Subscribe To Drug Industry Daily